Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

Women diagnosed with incomplete abortion in this health facility will be randomized to receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion with misoprostol using 400 mcg administered sublingually will be as effective as surgical evacuation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• no contraindications to misoprostol

• uterine size was not larger than 12 weeks

• there were no signs of severe infection

• haemodynamically stable

• in general good health

• willing to provide contact information

Exclusion Criteria:

• an IUD in place

• ectopic pregnancy

• aged below 18 years and had no accompanying adult to provide informed consent